Ribozymes and Riboswitches: Modern Biological Descendants from the Ancient RNA World?
Dr. Breaker has been invited by the School of Chemistry and Materials Science.
Dr. Breaker is coming from Yale to discuss his research on RNA and Ribozymes. He is the PI for the Breaker Lab.
From his website:
“Of special interest are ribozymes and riboswitches - RNA molecules that catalyze chemical reactions or that serve as chemical sensors and gene control elements. We employ a wide range of bioinformatics, genetics, and biochemical techniques to discover and study these functional RNAs - some of which might be ‘molecular relics’ from primitive life forms that have been extinct for billions of years.”
If you saw The Imitation Game you have a picture of Alan Turing as solitary, difficult to deal with, and a victim of prejudice. Yet Alan Turing claims achievements in pure mathematics, philosophy, cryptology, computer science, artificial intelligence, and developmental biology. Sir Dermot Turing, the author of the most recent biography of his famous uncle, challenges the conventional perception of Alan Turing. Using illustrations of Alan Turing's work and personal accounts of what he was like to work with, this presentation by Sir Dermot Turing will follow the course of Alan Turing's achievements, describe how he actually did arrive at his ideas, and assess the tragic events at the end of his life.
The Imitation Game Thursday - 10/12, 09:00 PM - 11:00 PM Student Alumni Union (SAU) Ingle Auditorium
Sir Turing's appearance is jointly part of the Golisano College of Computing and Information Sciences Dean's Lecture Series and the College of Science Distinguished Lecture Series.
Following the lecture, Sir Turing will sign copies of his book Prof: Alan Turing Decoded.
Moments after the Big Bang, our observable universe underwent a violent growth spurt called inflation. The inflationary expansion flung apart the observable universe from a causally-connected sub-atomic volume, and established a primordial spectrum of scalar perturbations that led to the temperature anisotropies observed in the cosmic microwave background. Dr. Bock's team has been making precise degree-scale polarization measurements of the CMB from the south pole with the BICEP/Keck series of experiments in search of a distinctive ‘B-mode’ pattern, a hallmark of tensor perturbations associated with a background of gravitational waves generated by inflation. Dr. Bock will present our latest results that incorporate multi-band information from the Planck satellite and new Keck Array data at 95 and 150 GHz. He will also discuss prospects from new data and improved measurements coming in the near future.
Supported by the John Wiley Jones Science Endowment Fund To request Interpreting Services, please visit myAccess.rit.edu.
In 1688, William Molyneux posed the following question to John Locke:
"Suppose a Man born blind … and taught by his touch to distinguish between a Cube, and a Sphere of the same [size and material]. Suppose then the Cube and Sphere placed on a Table, and the Blind Man to be made to see. [… C]ould [he] now distinguish, and tell, which is the Globe, which the Cube."
Molyneux’s question went on to spawn considerable philosophical discussion about the theory and origin of concepts and how novel experience is related and integrated into our cognitive worldview. But - an actual empirical investigation into the basic question has been difficult to perform as recovery from congenital blindness is almost impossibly rare. In 2003, our colleague, Pawan Sinha, performed one of the first empirical tests of Molyneux’s question as part of Project Prakash - a program with research, humanitarian, and educational missions aimed at vision restoration. Here, we will discuss our research into the interaction of vision and touch as well as highlights of Project Prakash.
Chris Garrett Novartis Pharmaceuticals Corporation
Friday, October 9, 2015
Pharmaceutical drug development is a process which can span over decades from target identification to end of product life cycle. Scientists are involved over this entire time frame covering aspects from basic science to program strategy and business performance. This talk will provide an introduction to the pharmaceutical development process. It will also highlight some of the scientific roles which must couple art and science to successfully develop and launch new therapies intended to address the unmet medical needs of patients around the world.